Advisory Services Network’s Standard BioTools LAB Stock Holding History

Advisory Services Network’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.97K	Buy	+6,490	New	+$7.86K	﹤0.01%	3775
2025 Q4	–	Sell	-6,490	Closed	-$8.44K	–	3189
2025 Q3	$8.44K	Buy	+6,490	New	+$8.5K	﹤0.01%	3351
2024 Q1	–	Sell	-500	Closed	-$1.1K	–	2670
2023 Q4	$1.1K	Buy	+500	New	+$1.07K	﹤0.01%	3512
2023 Q2	–	Sell	-500	Closed	-$975	–	2649
2023 Q1	$975	Hold	500	–	–	﹤0.01%	3621
2022 Q4	$585	Buy	+500	New	+$616	﹤0.01%	3711

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Advisory Services Network's LAB Position: Q1 2026 in Review

Advisory Services Network opened a new position in Standard BioTools (LAB) in Q1 2026: 6,490 shares worth $5.97K. The stake represents ﹤0.01% of the portfolio and ranks #3775 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in LAB as recently as Q3 2025.

Advisory Services Network first reported a position in LAB in Q4 2022 and has held it in 5 quarters since. The position peaked at $8.44K in Q3 2025. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

Advisory Services Network held 6,490 shares of Standard BioTools worth $5.97K as of Q1 2026.
Standard BioTools was a new Advisory Services Network position in Q1 2026.
Standard BioTools made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #3775 holding.
Advisory Services Network first reported a position in Standard BioTools in Q4 2022 and has held it in 5 quarters since.
Advisory Services Network's Standard BioTools position peaked at $8.44K in Q3 2025.
155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.